NEW YORK, July 10 – Sequenom of San Diego said Tuesday it had sold five MassArray systems, bringing the total number sold in the second quarter to nine.

The buyers include BioServe Biotechnologies, Centagenetix, Indiana University School of Medicine, LGC, and one undisclosed party. 

"We continue to experience an increasing demand for our MassArray product line," Toni Schuh, CEO of Sequenom, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.